Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wama Diagnóstica is a Brazilian in vitro diagnostics company focused on the research, development, production, and commercialization of laboratory diagnostic reagents, rapid tests, and analyzers. Founded in 1991, the company has built a broad commercial portfolio spanning immunodiagnostic kits, lateral flow rapid tests, urine strips, coagulation analyzers, electrolyte analyzers, urine analyzers, and sample-preparation equipment. Its product lineup addresses routine clinical laboratory and hospital needs across infectious disease testing, tropical diseases, pregnancy and fertility, blood typing, cardiac markers, tumor markers, coagulation, urinalysis, and electrolyte measurement. Wama emphasizes domestic manufacturing in Brazil, including immunochromatographic tests and urine strips, and highlights ISO 13485, ISO 9001, ANVISA GMP, and CE-mark coverage for much of its portfolio. The company distributes through authorized dealers in Brazil and internationally across Latin America and parts of Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wama Diagnóstica.